[1] HIGGS A, MCGRATH B A, GODDARD C, et al. Guidelines for the management of tracheal intubation in critically ill adults[J]. Br J Anaesth, 2018, 120(2):323-352.
[2] HILLEL A T, DING D, SAMAD I, et al. T-helper 2 lymphocyte immunophenotype is associated with iatrogenic laryngo-tracheal stenosis[J]. The Laryngoscope, 2019, 129(1):177-186.
[3] MORRISON R J, KATSANTONIS N G, MOTZ K M, et al. Pathologic fibroblasts in idiopathic subglottic stenosis amplify local inflammatory signals[J]. Otolaryngol Head Neck Surg, 2019, 160(1):107-115.
[4] MOTZ K M, YIN L X, SAMAD I, et al. Quantification of inflammatory markers in laryngotracheal stenosis[J]. Otolaryngol Head Neck Surg, 2017, 157(3):466-472.
[5] SZABO D, KOVACS D, ENDRESZ V, et al. Antifibrotic effect of mitomycin-c on human vocal cord fibroblasts[J]. The Laryngoscope, 2019, 129(7):255-262.
[6] YIN L X, MOTZ K M, SAMAD I, et al. Fibroblasts in hypoxic conditions mimic laryngotracheal stenosis[J]. Otolaryngol Head Neck Surg, 2017, 156(5):886-892.
[7] CHAN E P, MHAWI A, CLODE P, et al. Effects of titanium(iv) ions on human monocyte-derived dendritic cells[J]. Metallomics, 2009, 1(2):166-174.
[8] GHESQUIERE B, WONG B W, KUCHNIO A, et al. Metabolism of stromal and immune cells in health and disease[J]. Nature, 2014, 511(7508):167-176.
[9] MA G, SAMAD I, MOTZ K, et al. Metabolic variations in normal and fibrotic human laryngotracheal-derived fibroblasts:a warburglike effect[J]. Laryngoscope, 2017, 127(3):107-113.
[10] ANIS M M, ZHAO Z, KHURANA J, et al. Translational genomics of acquired laryngotracheal stenosis[J]. Laryngoscope, 2014, 124(5):175-179.
[11] ANIS M M, KRYNETSKAIA N, ZHAO Z, et al. Determining candidate single nucleotide polymorphisms in acquired laryngotracheal stenosis[J]. Laryngoscope, 2018, 128(3):111-116.
[12] PEARSON J P, PARIKH S, ORLANDO R C, et al. Review article:reflux and its consequences the laryngeal, pulmonary and oesophageal manifestations.Conference held in conjunction with the 9th international symposium on human pepsin(ISHP) Kingston-upon-Hull, UK, 21-23 April 2010[J]. Aliment Pharmacol Ther, 2011, 33(1):1-71.
[13] GELBARD A, FRANCIS D O, SANDULACHE V C, et al. Causes and consequences of adult laryngotracheal stenosis[J]. Laryngoscope, 2015, 125:1137-1143.
[14] STOVOLD R, FORREST I A, CORRIS P A, et al. Pepsin, a biomarker of gastric aspiration in lung allografts[J]. Am J Respir Crit Care Med, 2007, 175:1298-1303.
[15] HURIYATI E, DARWIN E, YANWIRASTI Y, et al. Laryngotracheal stenosis:a retrospective analysis of their aetiology, diagnose and treatment[J]. Open Access Maced J Med Sci, 2019, 31(10):1649-1656.
[16] 荆朝辉, 焦国庆, 荣晓松, 等.高流量鼻导管吸氧治疗心脏外科术后低氧血症的效果分析[J]. 东南大学学报(医学版), 2019, 38(4):718-721.
[17] SANTOS P M, AFRASSIABI A, WEYMULLER E A J R.Risk factors associated with prolonged intubation and laryngeal injury[J]. Otolaryngol Head Neck Surg, 1994, 111(4):453-459.
[18] MARSTON A P, WHITE D R.Sbglottic stenosis[J]. Clin Perinatol, 2018, 45(4):787-804.
[19] HALUM S L, TING J Y, PLOWMAN E K, et al. A multiinstitu tional analysis of tracheotomy complications[J]. Laryngoscope, 2012, 122:38-45.
[20] PETREANU C A, SAVU C, SAON C, et al. The montgomery tracheal prosthesis:actual solution for tracheal stenosis[J]. Pneumologia, 2014, 63(1):26-31.
[21] DE VIRGILIO A, GRECO A, GALLO A, et al. Tracheostomal stenosis clinical risk factors in patients who have undergone total laryngectomy and adjuvant radiotherapy[J]. Eur Arch Otorhinolaryngol, 2013, 270(12):3187-3189.
[22] LORENZ R R.Adult laryngotracheal stenosis:etiology and surgical management[J]. Curr Opin Otolaryngol Head Neck Surg, 2003, 11(6):467-472.
[23] WRIGHT C D, LI S, GELLER A D, et al. Postintubation tracheal stenosis:management and results 1993 to 2017[J]. Ann Thorac Surg, 2019, 108(5):1471-1477.
[24] SASAKI C T, HORIUCHI M, KOSS N.Tracheostomy-related subglottic stenosis:bacteriologic pathogenesis[J]. Laryngoscope, 2010, 89(6):857-865.
[25] GELBARD A, FRANCIS D O, SANDULACHE V C, et al. Causes and consequences of adult laryngotracheal stenosis[J]. Laryngoscope, 2015, 125(5):1137-1143.
[26] LITTLE F B, KOUFMAN J A, KOHUT R I, et al. Effect of gastric acid on the pathogenesis of subglottic stenosis[J]. Ann Otol Rhinol Laryngol, 1985, 94:516-519.
[27] Ramareddy R S, ALLADI A.Review of esophageal injuries and stenosis:lessons learn and current concepts of management[J]. Indian Assoc Pediatr Surg, 2016, 21(3):139-143.
[28] FARZANEGAN R, FARZANEGAN B, ALEHASHEM M, et al. Item selection and content validity of the risk factors of post-intubation tracheal stenosis observation questionnaire for icuadmitted patients[J]. Tanaffos, 2017, 16(1):22-33.
[29] LYONS M, VLASTARAKOS P V, NIKOLOPOULOS T P.Congenital and acquired develop-mental problems of the upper airway in newborns and infants[J]. Early Hum Dev, 2012, 88(12):951-955.
[30] DURDEN F, SOBOL S E.Balloon laryngoplasty as a primary treatment for subglottic stenosis[J]. Arch Otolaryngol Head Neck Surg, 2007, 133(8):772-775.
[31] DE ALARCON A, RUTTER M J.Cervical slide tracheoplasty[J]. Arch Otolaryngol Head Neck Surg, 2012, 138(9):812-816.
[32] LANG M, BRIETZKE S E.A systematic review and meta-analysis of endoscopic balloon dilation of pediatric subglottic stenosis[J]. Otolaryngol Head Neck Surg, 2014, 150(2):174-179.
[33] SOONG W J.Pediatric interventional flexible bronchoscopy[J]. Pediatr Respirol Crit Care Med, 2018, 2:38-44.
[34] SIMPSON G T, STRONG M S, HEALY G B, et al. Predictive factors of success or failure in the endoscopic management of laryngeal and tracheal stenosis[J]. Ann Otol Rhinol Laryngol, 1982, 91:384-388.
[35] YAMAMOTO K, KOJIMA F, TOMIYAMA K, et al, Meta-analysis of therapeutic procedures for acquired subglottic stenosis in adults[J]. Ann Thorac Surg, 2011, 91:1747-1753.
[36] SICILIANI A S, RENDINA E A, IBRAHIM M, et al. State of the art in tracheal surgery:a brief literature review[J]. Multidisciplinary Respiratory Medicine, 2018, 13:34-41.
[37] 王亚洲, 张笃飞.布地奈德持续雾化吸入联合肺表面活性物质对新生儿呼吸窘迫综合征的临床疗效分析[J]. 现代医学, 2018, 46(11):1243-1246.
[38] MALDONADO F, LOISELLE A, DEPEW Z S, et al. Idiopathic subglottic stenosis:an evolving therapeutic algorithm[J]. Laryngoscope, 2014, 124:498-503.
[39] PARKER N P, BANDYOPADHYAY D, MISONO S, et al. Endoscopiccold incision, balloon dilation, mitomycin c application, and steroid injection for adult laryngotracheal stenosis[J]. Laryngoscope, 2013, 123:220-225.
[40] REICHERT L K, ZHAO A S, GALATI L T, et al. The efficacy of mitomycin c in the treatment of laryngotracheal stenosis:results and experiences with a difficult disease entity[J]. ORL J Otorhinolaryngol Relat Spec, 2015, 77(6):351-358.
[41] 方广东, 贾贝贝, 陈长春, 等.极低出生体重儿支气管肺发育不良的高危因素及防治[J]. 东南大学学报(医学版), 2020, 39(4):430-435.
[42] SMITH M E, ELSTAD M.Mitomycin C and the endoscopic treatment of laryngotracheal stenosis:are two applications better than one[J]. Laryngoscope, 2009, 119:272-283.
[43] MIZOKAMI D, ARAKI K, TANAKA N, et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model[J]. Laryngoscope, 2015, 125:210-215.
[44] DUVVURI M, MOTZ K, MURPHY M, et al. Engineering an immunomodulatory drug-eluting stent to treat laryngotracheal stenosis[J]. Biomaterials science, 2019, 7(5):1863-1874. |
